RxDoctor Payments Data

Nathan Hensley, DPM

Foot & Ankle Surgery · Lima, OHNPI 1992068589

Payments from drug & device makers

What this record shows

The money is spread across several categories — consulting fees (53.9%), education and travel and lodging — rather than concentrated in one kind of arrangement. 17 manufacturers reported payments, led by Arteriocyte Medical Systems, Inc. at 39.6% of the total. Reporting peaked in 2019 at $9,217 and has fallen 89.0% since, to $1,018 in 2025.

$16,477in general payments, 2019–2025

Across 75 payments — averaging $219.69 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Arteriocyte Medical Systems, Inc.$7K
  • Crossroads Extremity Systems, LLC$3K
  • Arthrex$3K
  • Stryker$2K
  • CDC Medical LLC$977
  • Integra Lifesciences Corporation$590
  • plus $601 from 11 others
$3,900in research payments, 2019–2025

Across 1 payment — averaging $3900.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Smith+Nephew$4K

What the payments were for

  • Consulting fees$8,88854%
  • Travel & lodging$2,43215%
  • Food & beverage$2,31514%
  • Education$2,59716%
  • Other$2451%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$16,477 in reported general payments places this provider in the 85th percentile of 429 foot & ankle surgery providers in Ohio.

See all foot & ankle surgery providers in Ohio

Medicare billing

Part B allowed, 2024
$178,828
Medicare patients
609
Services billed
3,544

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen264$2,892
Gabapentin117$1,680
Pregabalin32$1,431
Celecoxib21$991
Cefadroxil120$893
Meloxicam284$892
Cyclobenzaprine Hcl115$864
Ciclopirox26$735
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen61$593
Doxycycline Hyclate75$560
Econazole Nitrate12$254
Prednisone120$246
Ketorolac Tromethamine19$238
Tramadol Hcl50$229
Ciprofloxacin Hcl27$212

Paid to pharmacies, not to this prescriber.

Other foot & ankle surgery in Lima

See the full list for Ohio

Where these figures come from

Is this you, or does something look wrong? →